Connection

Allen Kaplan to Risk Factors

Back to Details
This is a "connection" page, showing publications Allen Kaplan has written about Risk Factors.
Allen Kaplan
Connection Strength
0.120
Risk Factors
  1. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. J Allergy Clin Immunol. 2016 Feb; 137(2):474-81.
    View in: PubMed
    Score: 0.062
  2. The thrombogenicity of C1 esterase inhibitor (human): review of the evidence. Allergy Asthma Proc. 2014 Nov-Dec; 35(6):444-53.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.